NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health [Internet]. Washington (DC): US Department of Health and Human Services; 2016 Nov.
Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health [Internet].
Show detailsRohypnol® (Flunitrazepam)
| A benzodiazepine chemically similar to prescription sedatives such as Valium® and Xanax®. Teens and young adults tend to abuse this drug at bars, nightclubs, concerts, and parties. It has been used to commit sexual assaults due to its ability to sedate and incapacitate unsuspecting victims.1 | ||||
|---|---|---|---|---|
| Common Commercial Names | Street Names | Common Forms | Common Ways Taken | DEA Schedule / Legal Status |
| Flunitrazepam, Rohypnol® | Circles, Date Rape Drug, Forget Pill, Forget-Me Pill, La Rocha, Lunch Money, Mexican Valium, Mind Eraser, Pingus, R2, Reynolds, Rib, Roach, Roach 2, Roaches, Roachies, Roapies, Rochas Dos, Roofies, Rope, Rophies, Row-Shay, Ruffies, Trip-and-Fall, Wolfies | Tablet | Ingested (as a pill or as dissolved in a drink), snorted | Schedule IV / Rohypnol® is not approved for medical use in the United States; it is available as a prescription sleep aid in other countries |
| Uses & Possible Health Effectsii | ||||
| Short-term Symptoms of Use | Drowsiness, sedation, sleep; amnesia, blackout; decreased anxiety; muscle relaxation, impaired reaction time and motor coordination; impaired mental functioning and judgment; confusion; aggression; excitability; slurred speech; headache; slowed breathing and heart rate. | |||
| Long-term Consequences of Use and Health Effectsiii | Physical and psychological dependence; cardiovascular collapse; and death | |||
| Other Health-related Issues | Sometimes used as a date rape drug. | |||
| In Combination with Alcohol | Exaggerated intoxication, severe sedation, unconsciousness, and slowed heart rate and breathing, which can lead to death. | |||
| Withdrawal Symptoms | Headache; muscle pain; extreme anxiety, tension, restlessness, confusion, irritability; numbness and tingling of hands or feet; hallucinations, delirium, convulsions, seizures, or shock. | |||
| Treatment Optionsiv | ||||
| Medications | There are no FDA-approved medications to treat addiction to Rohypnol® or other prescription sedatives. | |||
| Behavioral Therapies | More research is needed to determine if behavioral therapies can be used to treat addiction to Rohypnol® or other prescription sedatives. | |||
| Statistics as of 2015v | ||||
| Prevalence | Lifetime: Data not collected. Past Year: Data not collected. | |||
| Average Age of Initiation | Sedatives in general: 23.4 | |||
- i
Source: NIDA, (2016).
- ii
Sources: NIDA, (2016) & DEA, (2015).
- iii
Source: Rohypnol Abuse Treatment, (n.d.).
- iv
Source: NIDA, (2016).
- v
Source: CBHSQ, (2016).
- [Table], Rohypnol® (Flunitrazepam) - Facing Addiction in America[Table], Rohypnol® (Flunitrazepam) - Facing Addiction in America
Your browsing activity is empty.
Activity recording is turned off.
See more...